Skip Nav Destination
Article navigation
Education|
December 1988
Plasma Levels of Dantrolene following Oral Administration in Malignant Hyperthermia-susceptible Patients
Gregory C. Allen, M.D., F.R.C.P.C.;
Gregory C. Allen, M.D., F.R.C.P.C.
*Resident in Anesthesia.
Search for other works by this author on:
Charles B. Cattran, M.D., F.R.C.P.C;
Charles B. Cattran, M.D., F.R.C.P.C
†Clinical Lecturer in Anesthesia.
Search for other works by this author on:
Robert G. Peterson, M.D., Ph.D.;
Robert G. Peterson, M.D., Ph.D.
‡Associate Professor of Pediatrics and Pharmacology.
Search for other works by this author on:
Marcel Lalande, Ph.D.
Marcel Lalande, Ph.D.
§Post-doctoral Pharmacology Fellow, Department of Pediatrics.
Search for other works by this author on:
Anesthesiology December 1988, Vol. 69, 900–904.
Citation
Gregory C. Allen, Charles B. Cattran, Robert G. Peterson, Marcel Lalande; Plasma Levels of Dantrolene following Oral Administration in Malignant Hyperthermia-susceptible Patients. Anesthesiology 1988; 69:900–904 doi: https://doi.org/10.1097/00000542-198812000-00016
Download citation file:
Citing articles via
Most Viewed
Related Articles
Induction of Malignant Hyperthermia in Susceptible Swine by 3,4-Methylenedioxymethamphetamine (“Ecstasy”)
Anesthesiology (November 2003)
4-Chloro-m-cresol is a Trigger of Malignant Hyperthermia in Susceptible Swine
Anesthesiology (June 1999)
Secretion of Dantrolene into Breast Milk after Acute Therapy of a Suspected Malignant Hyperthermia Crisis during Cesarean Section
Anesthesiology (October 1998)
Intramuscular Injection of Sevoflurane Detects Malignant Hyperthermia Predisposition in Susceptible Pigs
Anesthesiology (October 2007)
Malignant Hyperthermia Testing in Probands without Adverse Anesthetic Reaction
Anesthesiology (September 2015)
